MF
MFGenie.ai
ETF📊 NIFTY PHARMA TRI

Nippon India Nifty Pharma ETF · Regular · Growth

Nippon India Mutual Fund

#39 of 232 (1Y)

NAV

₹24.8001

as of 16 Jun 2026

Expense Ratio

see scheme documents

AUM

₹1,050 Cr

Viewing Regular · Growth

Lumpsum returns (CAGR)

1Y
+10.27%
3Y
+22.80%
5Y
Since Inception
+11.61%

SIP returns (XIRR)

1Y
+15.59%
3Y
+14.72%
5Y
Since Inception
+16.09%

SIP since inception — what ₹500/month became

Real NAV backtest from day one

₹29,500

Invested

₹43,981

Value today

16.6%

XIRR (p.a.)

500/month SIP from fund inception · Current value as of today

Try SIP Calculator with this fund's history

1,000 lumpsum at launch — value today

Invested on the fund's first NAV date

₹1,000

Invested

₹1,732

Value today

11.8%

CAGR (p.a.)

One-time investment at fund inception · Growth purely from NAV appreciation

Try Lumpsum Calculator

₹6L corpus via 12-month STP from a liquid fund at inception

₹50K/month transferred from HDFC Liquid → this fund at launch

₹6,00,000

Invested

₹11,15,933

Value today

+7.4%

vs lumpsum

STP beat direct lumpsum by 7.4% — reduced timing risk paid off

Model your own STP with real NAV

Risk Metrics

Trailing 1 year, annualised

-0.01

Sharpe Ratio

Alpha

Beta

-0.01

Sortino

16.13%

Std Dev

-15.71%

Max Drawdown

Performance Comparison

Thinking about Nippon India Nifty Pharma ETF · Regular · Growth?

Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.

+91

By submitting, you agree to our Privacy Policy. No spam, ever.

Fund Details

Fund HouseNippon India Mutual Fund
CategoryETF
BenchmarkNIFTY PHARMA TRI
Launch Date06 Jul 2021
AMFI Code149008
Transaction facts

Available transactions

Demat

Investment Objective

Nippon India Nifty Pharma ETF · Regular · Growth is an exchange-traded fund (ETF) that trades on stock exchanges like a regular share. It offers real-time pricing, low expense ratios, and the flexibility to buy and sell units throughout the trading day.

About This Fund

Nippon India Nifty Pharma ETF · Regular · Growth is a ETF mutual fund offered by Nippon India Mutual Fund. The fund has been operational for over 4 years. It manages assets worth ₹1,050 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY PHARMA TRI.

Who Should Invest?

  • Investors with a high risk appetite seeking long-term wealth creation
  • Investors with an investment horizon of 5 years or more
  • Cost-conscious investors who prefer passive investing with low expense ratios
  • SIP investors who can benefit from rupee cost averaging during market fluctuations